Filing Details

Accession Number:
0000769993-20-000186
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-02-18 19:12:09
Reporting Period:
2019-09-19
Accepted Time:
2020-02-18 19:12:09
Original Submission Date:
2019-09-30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879682 Viveve Medical Inc. VIVE () NY
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
769993 Goldman Sachs & Co. Llc 200 West Street
New York NY 10282
No No No No
886982 Goldman Sachs Group Inc 200 West Street
New York NY 10282
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Units Disposition 2019-09-20 1,658 $0.00 51,384 No 4 S Indirect See Footnotes
Common Units Acquisiton 2019-09-23 39,600 $5.84 90,984 No 4 P Indirect See Footnotes
Common Units Disposition 2019-09-23 800 $6.05 90,184 No 4 S Indirect See Footnotes
Common Units Acquisiton 2019-09-24 26,200 $5.64 116,384 No 4 P Indirect See Footnotes
Common Units Disposition 2019-09-24 800 $5.57 115,584 No 4 S Indirect See Footnotes
Common Units Disposition 2019-09-25 10,799 $5.62 104,785 No 4 S Indirect See Footnotes
Common Units Disposition 2019-09-26 7,001 $5.25 97,784 No 4 S Indirect See Footnotes
Common Units Disposition 2019-09-27 5,359 $5.10 92,425 No 4 S Indirect See Footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 P Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
No 4 S Indirect See Footnotes
Footnotes
  1. This statement is being filed by The Goldman Sachs Group, Inc. ("GS Group") and Goldman Sachs & Co. LLC ("Goldman Sachs" and together with GS Group, the "Reporting Persons"). Goldman Sachs is a subsidiary of GS Group. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein.
  2. The Common Units of the Issuer reported herein as indirectly purchased were beneficially owned directly by Goldman Sachs and indirectly by GS Group.
  3. This submission is made to amend the Reporting Persons' submission of a Statement of Beneficial Ownership of securities filed on September 30, 2019 and October 23, 2019 (the "Original Submission"). After making the Original Submission, the Reporting Persons determined in consultation with Viveve Medical, Inc. ("Issuer") that the Reporting Persons' ownership did not at any time exceed 10% of Issuer's outstanding securities. As such, none of the transactions previously reported in the Reporting Persons' Original Submission were subject to reporting under Section 16.